Analytical Data
-
Gene name
PSR
- Application
-
Alternative Names
JMJD6; PTDSR; Jumonji Domain Containing 6; JmjC domain-containing protein 6; Bifunctional Arginine Demethylase And Lysyl-Hydroxylase; Peptide-lysine 5-dioxygenase JMJD6
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6NYC1
-
Expression Region
Met1~Glu334
-
Molecular Weight
43kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of PSR (Psychoactive Substance Receptor) proteins has gained significant attention in the fields of neuroscience and pharmacology due to their critical role in mediating the effects of various psychoactive substances, including drugs and neurotransmitters. PSR proteins are involved in complex signaling pathways that influence mood, cognition, and behavior, making them pivotal targets for understanding the mechanisms underlying mental health disorders such as depression, anxiety, and schizophrenia. Recent advancements in structural biology and bioinformatics have facilitated the exploration of PSR protein structures, providing insights into their functional mechanisms and interaction with ligands. Researchers have been particularly focused on the receptor's dynamic nature, which may contribute to varying responses to psychoactive substances among individuals. Additionally, the potential for PSR proteins to serve as biomarkers for psychiatric conditions underscores their importance in developing targeted therapies. Ongoing studies aim to elucidate the therapeutic implications of modulating PSR activity, highlighting their promise in the design of novel pharmacological interventions. As the understanding of PSR proteins evolves, so does the potential for innovative strategies to combat the global challenges posed by mental health disorders.
